TrialBMC gastroenterology2020

A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis.

Larissa Akeme Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.